You searched for patient lawsuits - Page 2 of 10

Testimony in supermodel stem cell fraud case: “I lied to patients”

July 18, 2012 / Professor Paul Knoepfler, Ph.D. / 6 Comments

“I lied to patients,” testified a weeping, young woman in court related to a fraud allegation involving stem cells. She had worked as an office assistant at a company that injected bogus and potentially dangerous cow-based “stem cell” treatments into human patients. This company, which in different incarnations went by various names including Biomark in […]

Testimony in supermodel stem cell fraud case: “I lied to patients” Read More »

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE)

April 29, 2011 / Professor Paul Knoepfler, Ph.D. / 2 Comments

A Federal Appeals Court ruled 2-1 today to overturn Judge Lamberth’s injunction against federal funding of ES cell research. Great news! You can read the decision here (warning: big pdf). A key part of the ruling was the following: “the plaintiffs are unlikely to prevail because Dickey-Wicker is ambiguous and the NIH seems reasonably to

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE) Read More »

Recent stem cell & regenerative medicine good news

April 30, 2024 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good

Recent stem cell & regenerative medicine good news Read More »

How much does stem cell therapy cost in 2023?

March 22, 2021 / Professor Paul Knoepfler, Ph.D.

One of the most common questions I’ve gotten over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much it should cost. To try to authoritatively answer this now in 2023 we need data from the present and past along with expert

How much does stem cell therapy cost in 2023? Read More »

FDA warns Joseph Mercola on COVID-19 claims

March 9, 2021 / Professor Paul Knoepfler, Ph.D. / 5 Comments

Those of you following the arena of unproven stem cells might recognize the name Dr. Joseph Mercola. He’s a promoter of alternative medicine. Over the years his name has also popped related to the marketing of unproven stem cell offerings in various ways. Now the FDA has warned Joseph Mercola on what it says are unapproved

FDA warns Joseph Mercola on COVID-19 claims Read More »

How much does stem cell therapy cost in 2022?

June 16, 2020 / Professor Paul Knoepfler, Ph.D. / 16 Comments

One of the most common questions that patients have asked me over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much the treatments should cost. To try to authoritatively answer this we need data from the present and past along

How much does stem cell therapy cost in 2022? Read More »

Bad Batch podcast’s dark picture of perinatal stem cell industry

November 20, 2019 / Professor Paul Knoepfler, Ph.D. / 4 Comments

I finished listening to the first 6 episodes of the Bad Batch podcast last week. The series is by medical journalist Laura Beil. I think there will be a 7th episode that’s a Q&A. I highly recommend listening to the series even if parts are wrenching at times like how much patients and families have

Bad Batch podcast’s dark picture of perinatal stem cell industry Read More »

Kristin Comella resigns from embattled clinic firm US Stem Cell

September 8, 2019 / Professor Paul Knoepfler, Ph.D. / 8 Comments

US Stem Cell, Inc. reports in a new SEC filing that its key leader Kristin Comella has resigned as of September 1. I never thought I’d see the day when Kristin Comella and US Stem Cell, Inc. parted ways. To me Comella seemed like the driving force behind the company, which is now subject to

Kristin Comella resigns from embattled clinic firm US Stem Cell Read More »

Can clinic biz US Stem reboot after losing suit? Its email to customers & more

July 2, 2019 / Professor Paul Knoepfler, Ph.D. / 2 Comments

The unproven stem cell clinic firm US Stem Cell Inc. is in a world of hurt. If a federal judge says you can no longer sell your key commercial offering, how do you survive as a company? US Stem probably has been thinking about that possibility for months. Still, it’s not yet clear where the

Can clinic biz US Stem reboot after losing suit? Its email to customers & more Read More »

In dark augur for clinic industry, court allows class action suit by 100s against Stemgenex

June 30, 2019 / Professor Paul Knoepfler, Ph.D. / 7 Comments

In the latest blow to the unproven stem cell clinic industry, a California federal district court judge just granted class status to a lawsuit against the fat stem cell clinic Stemgenex. (update: Stemgenex has since filed for bankruptcy). What this means in practical terms is that the lawsuit alleging fraud in marketing by the clinic

In dark augur for clinic industry, court allows class action suit by 100s against Stemgenex Read More »

Search Results for: patient lawsuits